NXTC NextCure, Inc.
Healthcare$7.02-10.34%ClosedMarket Cap: $18.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.54
P/S
0.00
EV/EBITDA
-0.18
DCF Value
$7.07
FCF Yield
-238.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-187.0%
ROA
-143.9%
ROIC
-180.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-10.1M | $-9.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-9.8M | $-9.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-57.6M | $-55.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-8.9M | $-8.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-27.3M | $-26.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-11.6M | $-11.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-12.5M | $-11.6M | $— | — |
| FY null | $0.00 | NaN% | $-59.7M | $-55.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-12.5M | $-11.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-16.5M | $-15.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-18.3M | $-17.1M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-15.8M | $-14.5M | $-6.22 | — |